Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
0.289
-0.009 (-2.89%)
At close: Mar 6, 2026, 4:00 PM EST
0.289
0.00 (0.01%)
After-hours: Mar 6, 2026, 7:59 PM EST
Plus Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 5.26 | 5.82 | 4.91 | 0.22 | - | 0.3 | Upgrade
|
| Revenue Growth (YoY) | -8.16% | 18.54% | 2093.30% | - | - | -95.67% | Upgrade
|
| Cost of Revenue | 7.62 | 10.58 | 9.69 | 9.7 | 5.32 | 2.7 | Upgrade
|
| Gross Profit | -2.37 | -4.76 | -4.78 | -9.47 | -5.32 | -2.4 | Upgrade
|
| Selling, General & Admin | 11.09 | 9.94 | 8.54 | 10.24 | 6.85 | 6.41 | Upgrade
|
| Operating Expenses | 11.09 | 9.94 | 8.54 | 10.24 | 6.85 | 6.41 | Upgrade
|
| Operating Income | -13.46 | -14.7 | -13.32 | -19.71 | -12.18 | -8.8 | Upgrade
|
| Interest Expense | -0.61 | -0.18 | -0.4 | -0.71 | -0.93 | -1.11 | Upgrade
|
| Interest & Investment Income | 0.14 | 0.27 | 0.4 | 0.15 | 0.02 | 0.05 | Upgrade
|
| Other Non Operating Income (Expenses) | -6.66 | 1.62 | - | 0 | 0.01 | 2.4 | Upgrade
|
| EBT Excluding Unusual Items | -20.58 | -12.98 | -13.32 | -20.28 | -13.08 | -7.46 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | -0.07 | - | Upgrade
|
| Pretax Income | -20.58 | -12.98 | -13.32 | -20.28 | -13.4 | -8.24 | Upgrade
|
| Earnings From Continuing Operations | -20.58 | -12.98 | -13.32 | -20.28 | -13.4 | -8.24 | Upgrade
|
| Net Income | -20.58 | -12.98 | -13.32 | -20.28 | -13.4 | -8.24 | Upgrade
|
| Net Income to Common | -20.58 | -12.98 | -13.32 | -20.28 | -13.4 | -8.24 | Upgrade
|
| Shares Outstanding (Basic) | 45 | 7 | 3 | 2 | 1 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 45 | 8 | 3 | 2 | 1 | 0 | Upgrade
|
| Shares Change (YoY) | 682.06% | 145.18% | 79.45% | 117.18% | 173.03% | 219.93% | Upgrade
|
| EPS (Basic) | -0.45 | -1.95 | -4.24 | -11.58 | -16.63 | -27.92 | Upgrade
|
| EPS (Diluted) | -0.46 | -2.34 | -4.24 | -11.58 | -16.65 | -27.92 | Upgrade
|
| Free Cash Flow | -15.78 | -10.7 | -13.01 | -13.48 | -10.42 | -8.53 | Upgrade
|
| Free Cash Flow Per Share | -0.35 | -1.39 | -4.14 | -7.70 | -12.93 | -28.89 | Upgrade
|
| Gross Margin | -45.00% | -81.66% | -97.23% | - | - | - | Upgrade
|
| Operating Margin | -255.91% | -252.32% | -271.14% | -8800.00% | - | -2905.28% | Upgrade
|
| Profit Margin | -391.33% | -222.84% | -271.04% | -9051.34% | - | -2719.80% | Upgrade
|
| Free Cash Flow Margin | -300.06% | -183.72% | -264.83% | -6018.30% | - | -2814.19% | Upgrade
|
| EBITDA | -12.96 | -13.97 | -12.69 | -19.09 | -11.78 | -8.44 | Upgrade
|
| EBITDA Margin | -246.42% | -239.90% | -258.35% | - | - | - | Upgrade
|
| D&A For EBITDA | 0.5 | 0.72 | 0.63 | 0.62 | 0.4 | 0.37 | Upgrade
|
| EBIT | -13.46 | -14.7 | -13.32 | -19.71 | -12.18 | -8.8 | Upgrade
|
| EBIT Margin | -255.91% | -252.32% | -271.14% | - | - | - | Upgrade
|
| Revenue as Reported | - | - | - | - | - | 0.3 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.